3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
47
Rectal Neoplasms
29
Stomach Neoplasms
24
Colorectal Neoplasms
24
Triple Negative Breast Neoplasms
18
Neoplasm Metastasis
10
Nasopharyngeal Carcinoma
10
Colonic Neoplasms
10
Locally Advanced Rectal Cancer
7
Esophageal Neoplasms
7
Biliary Tract Neoplasms
7
Brain Neoplasms
5
Adenocarcinoma Of Esophagus
5
Adenocarcinoma
5
Pancreatic Neoplasms
4
Neoplasms
4
Gastrointestinal Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neuroendocrine Tumors
3
HER2-positive Breast Cancer
3
Cholangiocarcinoma
3
Advanced Solid Tumors
3
Recurrence
2
Neoplasm, Residual
2
Meningeal Neoplasms
2
Locally Advanced Colorectal Cancer
2
Esophageal Squamous Cell Carcinoma
2
Early Low Rectal Cancer
2
Colorectal Cancer Metastatic
2
Interventions
durvalumab
1
Surgical Procedures, Operative
1
Specimen Handling
1
Platinum
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Gemcitabine
1
Disulfides
1
Cisplatin
1
Capecitabine
1
Biopsy
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Resectable Intrahepatic Cholangiocarcinoma
×
Capecitabine
×
Clear all
NCT05265208
2025-08-06
SIROCHO
Center Eugene Marquis
Phase 2
Recruiting
62 enrolled